May 2, 2025 07:00 AM EDTUpdated 09:02 AM
Peer Review

For­mer Tome CEO joins Flag­ship start­up; NGM Bio chief steps down as re­struc­tur­ing takes ef­fect

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Ryan Cross

Senior Science Correspondent

Flag­ship Pi­o­neer­ing has re­cruit­ed Rahul Kakkar to lead its ge­net­ics-based drug dis­cov­ery start­up Quo­tient Ther­a­peu­tics. Kakkar was most re­cent­ly CEO of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

The ‘MA­HA re­port’: Four key take­aways on vac­cines, med­i­cine and the phar­ma in­dus­try

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

FDA chief to sen­a­tors: 3,000+ staff de­par­tures won't de­lay user fee tar­gets

House pass­es Trump tax bill with PBM and or­phan drug re­forms in­clud­ed

Post-Hoc: AI bio needs to heed the over­hyped his­to­ry of CRISPR

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times